Scinovex
reviewTop 1% cited

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

Leukemia · 2008 · Vol. 23(1) · pp. 43–52
Jan A. BurgerAmnon Peled
Chemokine receptors and signalingImmunotherapy and Immune ResponsesMultiple Myeloma Research and TreatmentsPlerixaforCXCR4Stromal cellLeukemiaHoming (biology)Cancer researchTumor microenvironmentStromal cell-derived factor 1HaematopoiesisBone marrow

MeSH terms

AnimalsAntineoplastic AgentsHumansLeukemiaNeoplasmsDrug Delivery SystemsTreatment OutcomeReceptors, CXCR4

Funding

  • CLL Global Research Foundation
  • Sidney Kimmel Foundation for Cancer Research
  • American Society of Clinical Oncology
  • Sidney Kimmel Foundation
Citations
458
FWCI
16.01
field-weighted impact
References
147
Percentile
99%
vs. same field & year
Citations per year
Cited by
A review on CXCR4/CXCL12 axis in oncology: No place to hide
European Journal of Cancer · 2012 · 623 citations
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Clinical Cancer Research · 2010 · 1,452 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.